How many insider declarations does 동구바이오제약 have?

동구바이오제약 has filed 25 insider declarations with DART (FSS).

Who is the top reporting insider at 동구바이오제약?

The top reporting insider at 동구바이오제약 is 조용준, based on the count of public filings.

What is the net insider buy vs sell volume on 동구바이오제약?

Across the available history, declared buys total 0 and disposals 0.

InsiderTradesSIGMA

InsidersTradesSigma

동구바이오제약 (006620.KQ) | Insider Transactions

← Companies ★ Sign in to follow

동구바이오제약: insider trades · South Korea · DART (FSS)

DART:company-07bedaKR·DART (FSS)Mcap 125.2Bn€

AMF ↗

Discover the full management transaction log of 동구바이오제약, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Market capitalisation: €125.2bn. The latest transaction was reported on 13 May 2026 (Other). Among the most active insiders: 조용준. The full history is openly available.

Insider Decl.

Thresholds

0 ops.

Buy Volume

10 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

4630.00 €

Analyst consensus

Income statement

Revenue242.69 Bn€

Gross profit144.50 Bn€60% margin

Net income50.27 Bn€20.7% margin

Balance sheet & cash

Market cap125.20 Bn€

Total debt128.78 Bn€

Free Cash Flow−24.74 Bn€

Last declaration on 13 May 2026

Declarations25 total

Executives●Other2DART

조

조용준

KRX

DART:20260513000598·13 May 2026